FDA Inspection 1050589 — United States Global Partners
The FDA completed an inspection of United States Global Partners on Feb 16, 2018 in Southlake, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 16, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Southlake, TX (United States)